Palibout 0.25 Injection
Marketer
Therdose Pharma Pvt Ltd
Salt Composition
Palonosetron (0.25mg)
Overview Palibout 0.25 Injection
Ondansetron 0.25mg injection is an anti-nausea medication frequently prescribed to manage vomiting and queasiness stemming from various medical issues, including gastrointestinal distress. Its use also extends to preventing nausea and vomiting associated with surgery, chemotherapy, or radiation therapy. However, this injection does not alleviate other cancer treatment side effects. Administered under medical supervision, it can be used independently or in conjunction with other treatments. Dosage is determined by your physician based on your specific needs. Continue injections as directed until your doctor advises discontinuation, potentially transitioning to oral medication thereafter. Common side effects include injection site discomfort, headache, and constipation. Drowsiness and dizziness are also possible; avoid driving or activities requiring alertness until the drug's effects are known. These effects typically subside upon cessation of treatment. Persistent or bothersome side effects warrant medical consultation. Prior to use, inform your doctor of any existing heart, liver, or gastrointestinal obstructions. Disclose all other medications, particularly those for epilepsy, cardiac conditions, cancer, or depression, as interactions may occur. Pregnant or breastfeeding individuals should seek guidance from their healthcare provider.
Primary Ingredients of Palibout 0.25 Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Palibout 0.25 Injection
Sickness | Emesis
Major Benefits of Palibout 0.25 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Palibout 0.25 Injection:
- Injection site pain
- Constipation
- Headache
- Diarrhea
- Dizziness
How to use Palibout 0.25 Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Palibout 0.25 Injection works:
Palibout 0.25 Injection is an anti-nausea drug. Its mechanism involves inhibiting serotonin, a neurotransmitter in the brain that triggers nausea and vomiting, often experienced following surgery or chemotherapy.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Palibout 0.25 Injection may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Palibout (0.25 mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Palibout 0.25 Injection while breastfeeding is likely safe. Available human data indicate minimal risk to the infant.
DrivingUNSAFE
Administering Palibout 0.25 Injection may induce drowsiness, blurred vision, or dizziness. Refrain from driving if such effects manifest.
KidneySAFE IF PRESCRIBED
Palibout 0.25 Injection poses no safety concerns for individuals with kidney impairment; dosage modification is unnecessary.
LiverSAFE IF PRESCRIBED
Palibout 0.25 Injection poses no safety concerns for individuals with hepatic impairment; dosage modification is unnecessary.
What if you forget to take Palibout 0.25 Injection :
Should you forget a Palibout 0.25 Injection, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Palibout 0.25 Injection
| Label | Value |
|---|---|
| Chemical Type | Isoquinoline and Quinuclidine Derivatives |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal System |
| Action Class | 5-HT3 receptor blockers |
3,018 People bought this recently